Free Trial

The Biotech Growth Trust (BIOG) Competitors

The Biotech Growth Trust logo
GBX 868 +5.00 (+0.58%)
(As of 12/20/2024 12:19 PM ET)

BIOG vs. EDIN, AGT, ASHM, GSS, FCSS, CGT, FSV, JPE, TRY, and IEM

Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Edinburgh Investment (EDIN), AVI Global Trust (AGT), Ashmore Group (ASHM), Genesis Emerging Markets Fund (GSS), Fidelity China Special (FCSS), Capital Gearing (CGT), Fidelity Investment Trust - Fidelity Special Values (FSV), JPMorgan Elect plc ­- Managed Growth (JPE), TR Property Investment Trust (TRY), and Impax Environmental Markets (IEM). These companies are all part of the "asset management" industry.

The Biotech Growth Trust vs.

The Biotech Growth Trust (LON:BIOG) and Edinburgh Investment (LON:EDIN) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends.

Edinburgh Investment received 4 more outperform votes than The Biotech Growth Trust when rated by MarketBeat users. Likewise, 64.66% of users gave Edinburgh Investment an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.

CompanyUnderperformOutperform
The Biotech Growth TrustOutperform Votes
82
64.06%
Underperform Votes
46
35.94%
Edinburgh InvestmentOutperform Votes
86
64.66%
Underperform Votes
47
35.34%

Edinburgh Investment has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Edinburgh Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Biotech Growth Trust£80.35M3.47£74.60M£2.07419.32
Edinburgh Investment£141.19M7.80£131.71M£0.83890.36

28.6% of The Biotech Growth Trust shares are held by institutional investors. Comparatively, 23.1% of Edinburgh Investment shares are held by institutional investors. 0.7% of The Biotech Growth Trust shares are held by company insiders. Comparatively, 4.1% of Edinburgh Investment shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

The Biotech Growth Trust has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, Edinburgh Investment has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

Edinburgh Investment has a net margin of 93.28% compared to The Biotech Growth Trust's net margin of 92.85%. The Biotech Growth Trust's return on equity of 21.57% beat Edinburgh Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
The Biotech Growth Trust92.85% 21.57% 12.39%
Edinburgh Investment 93.28%11.58%6.69%

In the previous week, Edinburgh Investment had 5 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 7 mentions for Edinburgh Investment and 2 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 1.96 beat Edinburgh Investment's score of 0.41 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Biotech Growth Trust
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Edinburgh Investment
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Edinburgh Investment beats The Biotech Growth Trust on 10 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOG vs. The Competition

MetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£278.89M£1.08B£3.71B£1.90B
Dividend YieldN/A4.70%4.43%5.55%
P/E Ratio419.32799.74418.741,821.81
Price / Sales3.471,457.421,744.90386,342.76
Price / Cash87.7464.8152.3428.54
Price / Book0.801.141.372.78
Net Income£74.60M£64.78M£359.98M£157.16M
7 Day Performance-1.92%-1.95%-1.62%-2.00%
1 Month Performance-5.86%-0.25%0.23%21.23%
1 Year Performance3.21%7.17%9.86%29.20%

The Biotech Growth Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOG
The Biotech Growth Trust
N/AGBX 868
+0.6%
N/A+2.5%£278.89M£80.35M419.32N/AInsider Trade
News Coverage
EDIN
Edinburgh Investment
N/AGBX 742.95
-1.1%
N/A+8.5%£1.11B£141.19M904.82N/A
AGT
AVI Global Trust
N/AGBX 238.50
-0.8%
N/A+10.8%£1.08B£137.36M858.93N/APositive News
ASHM
Ashmore Group
0.538 of 5 stars
GBX 160.20
-0.7%
GBX 174
+8.6%
-28.2%£1.06B£186.80M1,152.86283
GSS
Genesis Emerging Markets Fund
N/AGBX 869
-1.0%
N/AN/A£1.06B£250.40M6.181,626Gap Down
FCSS
Fidelity China Special
N/AGBX 215.50
-0.5%
N/A+6.1%£1.02BN/A4,330.00N/APositive News
CGT
Capital Gearing
N/AGBX 4,765
-0.5%
N/A+2.7%£1.02B£-9,860,000.00-7,573.93N/A
FSV
Fidelity Investment Trust - Fidelity Special Values
N/AGBX 310
-1.6%
N/A+12.0%£1.00B£11.88M-31,500.0025,000
JPE
JPMorgan Elect plc ­- Managed Growth
N/AGBX 937.50
flat
N/AN/A£1.00B£104.78M1,250.00N/A
TRY
TR Property Investment Trust
N/AGBX 303
-1.6%
N/A-11.3%£961.57M£-528,720,000.00-173.1526News Coverage
Positive News
IEM
Impax Environmental Markets
N/AGBX 377
-0.8%
N/A-5.1%£946.57M£1.57M-9,450.00N/ANews Coverage
Positive News

Related Companies and Tools


This page (LON:BIOG) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners